key: cord-0755135-w8m2eimh authors: Yates, Thomas; Razieh, Cameron; Zaccardi, Francesco; Davies, Melanie J.; Khunti, Kamlesh title: Obesity and risk of COVID-19: analysis of UK Biobank date: 2020-05-28 journal: Prim Care Diabetes DOI: 10.1016/j.pcd.2020.05.011 sha: 29fe9f6e712a51794aee815f965308c33982a404 doc_id: 755135 cord_uid: w8m2eimh nan Thomas Yates, PhD 1, 2 ty20@leicester.ac.uk, Cameron Razieh, MSc 1, 2 cr288@leicester.ac.uk Francesco Zaccardi, PhD 1, 3 fz43@leicester.ac.uk, Melanie J Davies, PhD 1, 2, PhD 1, 3, 4, 5 Whilst emerging evidence has suggested that those with cardiometabolic diseases are at higher risk of severe COVID-19 and resulting complications, less is known about the relative importance of related lifestyle factors. Obesity in particular is associated with impaired pulmonary function, a suppressed immune system and has been identified as a risk factor in previous infectious outbreaks. 1 Obesity also appears to be prevalent in subjects with COVID-19. 1,2 However, as recently highlighted, there is a lack of information regarding the nature of association between body mass index (BMI) and COVID-19. 3 In order to inform this area, we investigated the association between obesity and laboratory confirmed COVID-19 within UK Biobank (application number 36371). Our hypothesis was that BMI and waist circumference would be independently associated with COVID-19. UK Biobank (https://www.ukbiobank.ac.uk/) is a large prospective cohort of 502,543 middle-aged adults. Assessments were conducted between March 2006 and July 2010. UK Biobank data are linked to national SARS-CoV-2 laboratory test data through Public Health England (PHE). Data provided included specimen origin (hospital inpatient indicating severe COVID-19 vs other settings). Data were available for the period 16 th March 2020 to 3 rd May 2020. We undertook logistic regression progressively adjusted for potential confounders (Figure 1 ). BMI was categorised as normal weight (18.5-<25 kg/m 2 ); overweight (25-<30 kg/m 2 ); obese (30-<35 kg/m 2 ); and severely obese (≥35 kg/m 2 ). Nonlinear effects were investigated using restricted cubic splines with knots placed at the 33 th and 66 th centile of variable distribution. Both BMI and waist circumference ( Figure 1 ) were associated with testing positive for COVID-19 in a dose-response fashion. Adjustment for possible confounders did not change the results. The adjusted odds ratio for overweight, obese and severely obese subjects was 1·31 (95% CI: 1·05, 1·62), 1·55 (1·19, 2·02), and 1·57 (1·14, 2·17), respectively, compared to normal weight. Interpretation was not affected if data were restricted to in-patients (severe cases) only (data not shown). Although limited by possible selection bias, these results provide early evidence for a dose-repose association between BMI, waist circumference and COVID-19. Further analysis on the association between obesity and COVID-19 complications, severity and mortality will be possible as UK Biobank data continues to be updated. This work was supported by the NIHR Leicester Biomedical Research Centre and NIHR Applied Research Centre East Midlands. Data was analysed using UK Biobank application number 36371 Role of the Funder/Sponsor The funder/sponsor had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. Obesity: the "Achilles heel" for COVID-19 Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the COVID-19 and obesity-lack of clarity, guidance, and implications for care Model 1: unadjusted Model 2 adjusted for: age, sex, ethnicity, social deprivation Model 3 adjusted for: Model 2 plus smoking status 25 kg/m 2 for BMI and 80 cm for waist circumference. Odds ratios (lines) and confidence intervals (areas) are plotted for ranges of BMI and waist circumference values (x axes) between the 2.5th and 97.5th centile of their distributions